Etubics' Grant - IV Round

Etubics raised a round of funding on February 26, 2011. Investors include National Cancer Institute.

Etubics Corporation is a clinical stage biotechnology company focused on developing immunotherapeutics for the treatment of cancer and vaccines against infectious diseases. The Company has a pipeline …

Articles about Etubics' Grant - IV Round: